23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

Jean-Philippe Encausse

Avec une IPO la société va passer un cap en cette période ou les BioTech se portent très bien.

23andMe is a leading consumer genetics and research company that offers a personalized health and wellness experience and has built a premier genetic